0001209191-22-046962.txt : 20220819
0001209191-22-046962.hdr.sgml : 20220819
20220819214005
ACCESSION NUMBER: 0001209191-22-046962
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220817
FILED AS OF DATE: 20220819
DATE AS OF CHANGE: 20220819
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kashmolah Ghazi
CENTRAL INDEX KEY: 0001877741
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39976
FILM NUMBER: 221182029
MAIL ADDRESS:
STREET 1: 1412 62ND STREET
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lucira Health, Inc.
CENTRAL INDEX KEY: 0001652724
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 272491037
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1412 62ND STREET
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (814) 574-1546
MAIL ADDRESS:
STREET 1: 1412 62ND STREET
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: DiAssess Inc.
DATE OF NAME CHANGE: 20150908
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-17
0
0001652724
Lucira Health, Inc.
LHDX
0001877741
Kashmolah Ghazi
1412 62ND STREET
EMERYVILLE
CA
94608
0
1
0
0
Ex VP & Chief Quality Officer
Common Stock
2022-08-17
4
S
0
19074
2.83
D
180757
D
Common Stock
2022-08-18
4
S
0
3500
2.25
D
177257
D
These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on September 30, 2021 for 197,240 shares.
Includes 2,591 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on February 20, 2022.
/s/ Dan George, Attorney-in-Fact for Ghazi Kashmolah
2022-08-19